Bioterrorism is terrorism involving the intentional release or dissemination of biological agents. These agents are bacteria, viruses, fungi, or toxins, and may be in a naturally occurring or a human-modified form, in much the same way in biological warfare.
Scope of the Report:
This report studies the Bioterrorism market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Bioterrorism market by product type and applications/end industries.
Bioterrorism refers to form of terrorism that involves intentional dissemination or release of biological agents. The agents can be viruses, bacteria or toxins and can also be referred to as germ warfare. Biological agents are mainly found in nature but sometimes they can be modified by the terrorist as to make agents more toxic. Biological agents are used by the terrorists to attain their social or political goals and are used for killing or injuring people, plants and animals. Biological weapons are dangerous as some of these agents are transmitted from one person to another and infection might take hours or days to become noticeable.
Bioterrorism is an invaluable tool as biological agents are relatively inexpensive and can cause widespread fear beyond the actual damage they can cause. They are mainly used by the terrorists to create mass panic and disruption of state or economy. The global market for bioterrorism is segmented on the type of different biological agents currently being used and their mode of delivery. Agents such as anthrax, tularemia, small pox, bubonic plague, botulinum toxin and viral hemorrhagic fevers pose a high threat to national security.
The global Bioterrorism market is valued at xx million in 2017 and is expected to reach xx million by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Bioterrorism.
Europe also play important roles in global market, with market size of xx million in 2017 and will be xx million in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Altimmune
Bavarian Nordic
DynPort Vaccine Company (DVC)
Emergent BioSolutions
Acambis
Achaogen
Cleveland BioLabs
Elusys Therapeutics
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Anthrax
Smallpox
Botulism
Radiation/Nuclear defense
Others
Market Segment by Applications, can be divided into
Military
Government
Frequently Asked Questions
Table Of Content
Table of Contents
1 Bioterrorism Market Overview
1.1 Product Overview and Scope of Bioterrorism
1.2 Classification of Bioterrorism by Types
1.2.1 Global Bioterrorism Revenue Comparison by Types (2017-2023)
1.2.2 Global Bioterrorism Revenue Market Share by Types in 2017
1.2.3 Anthrax
1.2.4 Smallpox
1.2.5 Botulism
1.2.6 Radiation/Nuclear defense
1.2.7 Others
1.3 Global Bioterrorism Market by Application
1.3.1 Global Bioterrorism Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Military
1.3.3 Government
1.4 Global Bioterrorism Market by Regions
1.4.1 Global Bioterrorism Market Size (Million ) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Bioterrorism Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Bioterrorism Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Bioterrorism Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Bioterrorism Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Bioterrorism Status and Prospect (2013-2023)
1.5 Global Market Size of Bioterrorism (2013-2023)
2 Manufacturers Profiles
2.1 Altimmune
2.1.1 Business Overview
2.1.2 Bioterrorism Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Altimmune Bioterrorism Revenue, Gross Margin and Market Share (2016-2017)
2.2 Bavarian Nordic
2.2.1 Business Overview
2.2.2 Bioterrorism Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bavarian Nordic Bioterrorism Revenue, Gross Margin and Market Share (2016-2017)
2.3 DynPort Vaccine Company (DVC)
2.3.1 Business Overview
2.3.2 Bioterrorism Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 DynPort Vaccine Company (DVC) Bioterrorism Revenue, Gross Margin and Market Share (2016-2017)
2.4 Emergent BioSolutions
2.4.1 Business Overview
2.4.2 Bioterrorism Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Emergent BioSolutions Bioterrorism Revenue, Gross Margin and Market Share (2016-2017)
2.5 Acambis
2.5.1 Business Overview
2.5.2 Bioterrorism Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Acambis Bioterrorism Revenue, Gross Margin and Market Share (2016-2017)
2.6 Achaogen
2.6.1 Business Overview
2.6.2 Bioterrorism Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Achaogen Bioterrorism Revenue, Gross Margin and Market Share (2016-2017)
2.7 Cleveland BioLabs
2.7.1 Business Overview
2.7.2 Bioterrorism Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Cleveland BioLabs Bioterrorism Revenue, Gross Margin and Market Share (2016-2017)
2.8 Elusys Therapeutics
2.8.1 Business Overview
2.8.2 Bioterrorism Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Elusys Therapeutics Bioterrorism Revenue, Gross Margin and Market Share (2016-2017)
3 Global Bioterrorism Market Competition, by Players
3.1 Global Bioterrorism Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Bioterrorism Players Market Share
3.2.2 Top 10 Bioterrorism Players Market Share
3.3 Market Competition Trend
4 Global Bioterrorism Market Size by Regions
4.1 Global Bioterrorism Revenue and Market Share by Regions
4.2 North America Bioterrorism Revenue and Growth Rate (2013-2018)
4.3 Europe Bioterrorism Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Bioterrorism Revenue and Growth Rate (2013-2018)
4.5 South America Bioterrorism Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Bioterrorism Revenue and Growth Rate (2013-2018)
5 North America Bioterrorism Revenue by Countries
5.1 North America Bioterrorism Revenue by Countries (2013-2018)
5.2 USA Bioterrorism Revenue and Growth Rate (2013-2018)
5.3 Canada Bioterrorism Revenue and Growth Rate (2013-2018)
5.4 Mexico Bioterrorism Revenue and Growth Rate (2013-2018)
6 Europe Bioterrorism Revenue by Countries
6.1 Europe Bioterrorism Revenue by Countries (2013-2018)
6.2 Germany Bioterrorism Revenue and Growth Rate (2013-2018)
6.3 UK Bioterrorism Revenue and Growth Rate (2013-2018)
6.4 France Bioterrorism Revenue and Growth Rate (2013-2018)
6.5 Russia Bioterrorism Revenue and Growth Rate (2013-2018)
6.6 Italy Bioterrorism Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Bioterrorism Revenue by Countries
7.1 Asia-Pacific Bioterrorism Revenue by Countries (2013-2018)
7.2 China Bioterrorism Revenue and Growth Rate (2013-2018)
7.3 Japan Bioterrorism Revenue and Growth Rate (2013-2018)
7.4 Korea Bioterrorism Revenue and Growth Rate (2013-2018)
7.5 India Bioterrorism Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Bioterrorism Revenue and Growth Rate (2013-2018)
8 South America Bioterrorism Revenue by Countries
8.1 South America Bioterrorism Revenue by Countries (2013-2018)
8.2 Brazil Bioterrorism Revenue and Growth Rate (2013-2018)
8.3 Argentina Bioterrorism Revenue and Growth Rate (2013-2018)
8.4 Colombia Bioterrorism Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Bioterrorism by Countries
9.1 Middle East and Africa Bioterrorism Revenue by Countries (2013-2018)
9.2 Saudi Arabia Bioterrorism Revenue and Growth Rate (2013-2018)
9.3 UAE Bioterrorism Revenue and Growth Rate (2013-2018)
9.4 Egypt Bioterrorism Revenue and Growth Rate (2013-2018)
9.5 Nigeria Bioterrorism Revenue and Growth Rate (2013-2018)
9.6 South Africa Bioterrorism Revenue and Growth Rate (2013-2018)
10 Global Bioterrorism Market Segment by Type
10.1 Global Bioterrorism Revenue and Market Share by Type (2013-2018)
10.2 Global Bioterrorism Market Forecast by Type (2018-2023)
10.3 Anthrax Revenue Growth Rate (2013-2023)
10.4 Smallpox Revenue Growth Rate (2013-2023)
10.5 Botulism Revenue Growth Rate (2013-2023)
10.6 Radiation/Nuclear defense Revenue Growth Rate (2013-2023)
10.7 Others Revenue Growth Rate (2013-2023)
11 Global Bioterrorism Market Segment by Application
11.1 Global Bioterrorism Revenue Market Share by Application (2013-2018)
11.2 Bioterrorism Market Forecast by Application (2018-2023)
11.3 Military Revenue Growth (2013-2018)
11.4 Government Revenue Growth (2013-2018)
12 Global Bioterrorism Market Size Forecast (2018-2023)
12.1 Global Bioterrorism Market Size Forecast (2018-2023)
12.2 Global Bioterrorism Market Forecast by Regions (2018-2023)
12.3 North America Bioterrorism Revenue Market Forecast (2018-2023)
12.4 Europe Bioterrorism Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Bioterrorism Revenue Market Forecast (2018-2023)
12.6 South America Bioterrorism Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Bioterrorism Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Inquiry For Buying
Bioterrorism
Request Sample
Bioterrorism
